ÂÜÀòÂÒÂ×

The Clinical Development & Research team at InterVenn Biosciences is dedicated to advancing precision medicine through innovative clinical and preclinical studies. They focus on the development and validation of glycoproteomic assays, data analysis, and regulatory compliance to support the efficacy and safety of new diagnostic and therapeutic solutions for various cancers. This multidisciplinary team collaborates to gather insights that drive patient stratification, monitor disease progression, and optimize treatment approaches.